98745749 - LIQUIDIA

Information

  • Trademark
  • 98745749
  • Serial Number
    98745749
  • Filing Date
    September 11, 2024
    a year ago
  • Transaction Date
    July 25, 2025
    10 months ago
  • Status Date
    July 22, 2025
    10 months ago
  • Published for Opposition Date
    May 27, 2025
    12 months ago
  • Location Date
    July 22, 2025
    10 months ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    PAYABYAB, EDWARD
  • Attorney Docket Number
    022214.0022
    Attorney Name
    Devon E. White
    Law Office Assigned Location Code
    O10
  • Owners
Mark Drawing Code
3
Mark Identification
LIQUIDIA
Case File Statements
  • GS0401: Custom manufacture of microparticles and nanoparticles, namely, those composed of polymers, excipients, therapeutics, and biologics, for general scientific and research purposes; Custom manufacture of microparticles and nanoparticles, namely, those composed of polymers, excipients, therapeutics, and biologics used for the manufacture of medical and pharmaceutical goods and for general scientific and research purposes; custom manufacture of microparticles and nanoparticles, namely, those composed of polymers, excipients, therapeutics, and biologics used for medical diagnostic and treatment purposes;
  • DM0000: The mark consists of a circle containing a hexagon and another circle. Three lines appear through all three shapes. The wording "LIQUIDIA" appears to the right of the design.
  • GS0051: Pharmaceuticals for treatment of respiratory diseases, namely, pharmaceuticals in the form of capsules comprised of microparticles and nanoparticles composed of polymers, excipients, therapeutics, and biologics; Pharmaceuticals for treatment of respiratory diseases, namely, pharmaceuticals in the nature of microparticles and nanoparticles with prophylactic properties composed of polymers, excipients, therapeutics, and biologics;
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Biological preparations in the nature of microparticles and nanoparticles comprised of polymers and excipients, used for the manufacture of medical and pharmaceutical goods and for general scientific and research purposes;
Case File Event Statements
  • 9/11/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 3/20/2025 - a year ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 3/20/2025 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/21/2025 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/21/2025 - a year ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/22/2025 - a year ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/21/2025 - a year ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/21/2025 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/22/2025 - a year ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/22/2025 - a year ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/21/2025 - a year ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/27/2025 - 12 months ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/24/2025 - a year ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/27/2025 - 12 months ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/24/2025 - 10 months ago
    17 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 7/24/2025 - 10 months ago
    16 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 7/22/2025 - 10 months ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM